📣 VC round data is live. Check it out!
- Public Comps
- Genting
Genting Valuation Multiples
Discover Genting's revenue and EBITDA valuation multiples and investment history, alongside public comparables like BTG Hotels Group, Resorttrust, Alrov Group, NagaCorp and more.
Genting Overview
About Genting
Genting Bhd is a diversified holdings company operating in the resorts and casinos industry. The company's primary business segment is Leisure & Hospitality, but the business has several smaller segments: Plantation, Power, Property, and Oil & Gas. The Leisure & Hospitality segment operates numerous resorts across various countries, many of which have casinos, theme parks, concerts, restaurants, and retail shopping locations. Additionally, the company has diversified segments, which control farmland, oil and gas, and real estate. The company generates the vast majority of its revenue from Malaysia and Singapore.
Founded
1968
HQ

Employees
54.0K
Website
Financials (LTM)
EV
$9B
Valuation Multiples
Start free trialGenting Financials
Genting reported last 12-month revenue of $7B and EBITDA of $2B.
In the same LTM period, Genting generated $904M in gross profit, $2B in EBITDA, and $62M in net income.
Revenue (LTM)
Genting P&L
In the most recent fiscal year, Genting reported revenue of $7B and EBITDA of $2B.
Genting is unprofitable as of last fiscal year, with gross margin of 28%, EBITDA margin of 28%, and net margin of (0%).
Financial data powered by Morningstar, Inc.
Genting Stock Performance
Genting has current market cap of $2B, and enterprise value of $9B.
Market Cap Evolution
Genting's stock price is $0.59.
Genting share price increased by 0.3% in the last 30 days, and decreased by 24.7% in the last year.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9B | $2B | 0.1% | 0.3% | 3.8% | -24.7% | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGenting Valuation Multiples
Genting trades at 1.2x EV/Revenue multiple, and 4.5x EV/EBITDA.
EV / Revenue (LTM)
Genting Financial Valuation Multiples
As of June 3, 2026, Genting has market cap of $2B and EV of $9B.
Genting has a P/E ratio of 36.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Genting Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Genting Margins & Growth Rates
Genting grew revenue by 3% and EBITDA by 0% in the last fiscal year.
In the most recent fiscal year, Genting reported gross margin of 28%, EBITDA margin of 28%, and net margin of (0%).
Genting Margins
Genting Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Genting Operational KPIs
Genting's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Genting's Rule of 40 is 33% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Genting's Rule of X is 41% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Genting Competitors
Genting competitors include BTG Hotels Group, Resorttrust, Alrov Group, NagaCorp, Monarch Casino & Resort, Cirsa Enterprises, Scandic Hotels, Sankyo, Kangwon Land and Hacksaw AB.
Most Genting public comparables operate across Casinos & Gambling and Accommodation.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.8x | 2.8x | 7.1x | 8.2x | |||
| 1.3x | 1.2x | 8.4x | 8.1x | |||
| 8.7x | - | 4.7x | - | |||
| 3.1x | 3.0x | 5.3x | 5.1x | |||
| 3.7x | 3.6x | 10.1x | 9.9x | |||
| 1.5x | 1.5x | 4.8x | 4.7x | |||
| 2.8x | 2.7x | 9.6x | 24.3x | |||
| 0.7x | 0.7x | 1.7x | - | |||
This data is available for Pro users. Sign up to see all Genting competitors and their valuation data. Start Free Trial | ||||||
Investments by Genting
Genting has invested in 3 companies to date.
Latest investment by Genting was on August 17th 2021. Genting invested in Sightline Payments in their $244M Undisclosed stage round (EV/Revenue multiple available to Pro users).
Latest Investments by Genting
| Description | Sightline Payments is a Henderson-headquartered provider of digital payment solutions for gaming and sports betting. Its Play+ platform enables cashless transactions across online, mobile, slots, table games, and sports wagering at major casino resorts and lotteries like Golden Nugget and BetMGM. Recognized as a leading gaming technology product, Play+ integrates with hospitality systems for seamless consumer experiences. | Sightline Payments is a Henderson-headquartered provider of digital payment solutions for gaming and sports betting. Its Play+ platform enables cashless transactions across online, mobile, slots, table games, and sports wagering at major casino resorts and lotteries like Golden Nugget and BetMGM. Recognized as a leading gaming technology product, Play+ integrates with hospitality systems for seamless consumer experiences. | Nova Satra Dx is a molecular diagnostics firm headquartered in Singapore developing blood-based cancer tests. Its NovoTect platform uses Oxford-developed epigenetic biomarkers for early detection of breast, colon, prostate, stomach, and lung cancers in Asian populations. | Applied Proteomics is a biotechnology firm advancing plasma proteomics for biomarker discovery in diagnostics and personalized medicine. The company deploys its TrueRead platform to quantify thousands of proteins from blood samples, enabling applications in cardiovascular disease and oncology. Headquartered in San Jose, California, Applied Proteomics partners with pharmaceutical companies to develop companion diagnostics and collaborates on clinical studies for precision healthcare. |
| HQ Country | ||||
| HQ City | Las Vegas, NV | Las Vegas, NV | Singapore | San Diego, CA |
| Deal Date | 17 Aug 2021 | 1 Apr 2021 | 4 Apr 2017 | 20 Aug 2013 |
| Round | Undisclosed stage | Undisclosed stage | Seed | Series C |
| Raised | $244M | $100M | $2M | $28M |
| Investors | Cannae Holdings; Genting; Point Break Capital Management; Walter Kortschak | Cannae Holdings; Genting; Kortschak Investments L.P.; Point Break Capital Management; Searchlight Capital Partners; Shift4 Ventures; Vectr; Walter Kortschak; William Foley II | Genting | Domain Associates; Genting; Vulcan Capital |
| Valuation | $1B | $1B | undisclosed | undisclosed |
| EV/Revenue | ||||
| EV/EBITDA | ||||
This data is available for Pro users. Sign up to see all Genting investments and their VC round multiples. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Genting
| When was Genting founded? | Genting was founded in 1968. |
| Where is Genting headquartered? | Genting is headquartered in Malaysia. |
| How many employees does Genting have? | As of today, Genting has over 54K employees. |
| Who is the CEO of Genting? | Genting's CEO is Kok Thay Lim. |
| Is Genting publicly listed? | Yes, Genting is a public company listed on Bursa Malaysia. |
| What is the stock symbol of Genting? | Genting trades under 3182 ticker. |
| When did Genting go public? | Genting went public in 1971. |
| Who are competitors of Genting? | Genting main competitors include BTG Hotels Group, Resorttrust, Alrov Group, NagaCorp, Monarch Casino & Resort, Cirsa Enterprises, Scandic Hotels, Sankyo, Kangwon Land, Hacksaw AB. |
| What is the current market cap of Genting? | Genting's current market cap is $2B. |
| What is the current revenue of Genting? | Genting's last 12 months revenue is $7B. |
| What is the current revenue growth of Genting? | Genting revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Genting? | Current revenue multiple of Genting is 1.2x. |
| What is the current EBITDA of Genting? | Genting's last 12 months EBITDA is $2B. |
| What is Genting's EBITDA margin? | Genting's last 12 months EBITDA margin is 28%. |
| What is the current EV/EBITDA multiple of Genting? | Current EBITDA multiple of Genting is 4.5x. |
| What is the current FCF of Genting? | Genting's last 12 months FCF is $26M. |
| What is Genting's FCF margin? | Genting's last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of Genting? | Current FCF multiple of Genting is 344.8x. |
| How many companies Genting has acquired to date? | Genting hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Genting has invested to date? | As of June 2026, Genting has invested in 3 companies. |
| What was the last Genting investment? | On 17th August 2021 Genting invested in Sightline Payments, participating in a $244M Undisclosed stage round at $1B valuation, alongside Cannae Holdings, Point Break Capital Management, and Walter Kortschak. |
| In what companies Genting invested in? | Genting invested in Sightline Payments, Applied Proteomics, and Nova Satra Dx. |
See public comps similar to Genting
Lists including Genting
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

